Search research articles
Contact Us
Filters
Showing results (111-120 of 133) with videos related to
Page
of 14
Sort By:
Hepatology (Baltimore, Md.)
|
May 22, 2025
Galectin-1 modulates glycolysis through a GM1-galactose-dependent pathway to promote hyperthermia resistance in HCC
Tu Nguyen, Yonghwan Shin, Aravinth Ruppa, et al.
Neuro-Oncology
|
March 11, 2024
Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma
Daniel C Moreira, Ibrahim Qaddoumi, Susan Spiller, et al.
Radiology
|
May 14, 2024
Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for Medulloblastoma
Qing Ji, Samuel S McAfee, Matthew Scoggins, et al.
Acta Neuropathologica
|
September 30, 2018
Structure and evolution of double minutes in diagnosis and relapse brain tumors
Ke Xu, Liang Ding, Ti-Cheng Chang, et al.
BMJ Open
|
July 19, 2018
GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice
John Furler, David Norman O'Neal, Jane Speight, et al.
Acta Neuropathologica
|
March 2, 2026
Pediatric H3 G34-mutant diffuse hemispheric glioma: clinical, imaging and molecular prognostic factors, MGMT expression, and temozolomide response
Dana Tlais, Qunyu Zhang, Jordan T Roach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2025
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, et al.
Neuro-Oncology
|
April 16, 2025
FOXR2 activation is not exclusive of CNS neuroblastoma
Alexa N Siskar, Emily Hanzlik, Maria F Cardenas, et al.
The Lancet. Diabetes & Endocrinology
|
December 22, 2019
Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial
John Furler, David O'Neal, Jane Speight, et al.
Acta Neuropathologica
|
November 18, 2019
YAP1-fusions in pediatric NF2-wildtype meningioma
Philipp Sievers, Jason Chiang, Daniel Schrimpf, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 133) with videos related to
Sort By:
Page
of 14
Hepatology (Baltimore, Md.)
|
May 22, 2025
Galectin-1 modulates glycolysis through a GM1-galactose-dependent pathway to promote hyperthermia resistance in HCC
Tu Nguyen, Yonghwan Shin, Aravinth Ruppa, et al.
Neuro-Oncology
|
March 11, 2024
Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma
Daniel C Moreira, Ibrahim Qaddoumi, Susan Spiller, et al.
Radiology
|
May 14, 2024
Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for Medulloblastoma
Qing Ji, Samuel S McAfee, Matthew Scoggins, et al.
Acta Neuropathologica
|
September 30, 2018
Structure and evolution of double minutes in diagnosis and relapse brain tumors
Ke Xu, Liang Ding, Ti-Cheng Chang, et al.
BMJ Open
|
July 19, 2018
GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice
John Furler, David Norman O'Neal, Jane Speight, et al.
Acta Neuropathologica
|
March 2, 2026
Pediatric H3 G34-mutant diffuse hemispheric glioma: clinical, imaging and molecular prognostic factors, MGMT expression, and temozolomide response
Dana Tlais, Qunyu Zhang, Jordan T Roach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2025
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, et al.
Neuro-Oncology
|
April 16, 2025
FOXR2 activation is not exclusive of CNS neuroblastoma
Alexa N Siskar, Emily Hanzlik, Maria F Cardenas, et al.
The Lancet. Diabetes & Endocrinology
|
December 22, 2019
Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial
John Furler, David O'Neal, Jane Speight, et al.
Acta Neuropathologica
|
November 18, 2019
YAP1-fusions in pediatric NF2-wildtype meningioma
Philipp Sievers, Jason Chiang, Daniel Schrimpf, et al.
Page
of 14